Analyst Ratings For ACIU – AC Immune (NASDAQ:ACIU)
Today, HC Wainwright initiated coverage on ACIU – AC Immune (NASDAQ:ACIU) with a Buy with a price target of $18.00.
Some recent analyst ratings include
- 4/5/2018-HC Wainwright initiated coverage with a Buy rating.
- 3/23/2018-Credit Suisse Group was Downgraded by analysts at Credit Suisse Group from a “Outperform ” rating to a ” Neutral” rating. They now have a $14.00 price target on the stock, up previously from $18.00 .
- 12/13/2016-Jefferies Group Reiterated Rating of Buy.
- 11/26/2016-Leerink Swann Reiterated Rating of Outperform.
Recent Trading Activity for ACIU – AC Immune (NASDAQ:ACIU)
Shares of ACIU – AC Immune closed the previous trading session at 10.97 up +0.17 1.57% with shares trading hands.